{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:59:37Z","timestamp":1790643577859,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T00:00:00Z","timestamp":1379289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074605","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T21:16:28Z","timestamp":1379366188000},"page":"e74605","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inactivated Orf Virus Shows Antifibrotic Activity and Inhibits Human Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Replication in Preclinical Models"],"prefix":"10.1371","volume":"8","author":[{"given":"Daniela","family":"Paulsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hirth-Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Siegling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Limmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Schumak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Knolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Ruebsamen-Schaeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,16]]},"reference":[{"key":"ref1","unstructured":"WHO: HCV. Fact Sheet N\u00b0 165."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/0264-410X(95)80050-N","article-title":"Global programme for control of hepatitis B infection","volume":"13","author":"M Kane","year":"1995","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"GL Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"HH Thein","year":"2008","journal-title":"Hepatology"},{"key":"ref5","first-page":"S1","article-title":"Nature","volume":"474","author":"C Nature Outlook Hepatitis","year":"2011"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"German HEP-NET Acute HCV Study Group Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"J Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Lange CM, Zeuzem S (2012) Perspectives and challenges of interferon-free therapy for chronic hepatitis C. J Hepatol Oct 24. pii: S0168\u20138278(12)00818\u20135. doi:10.1016\/j.jhep.2012.10.019. [Epub ahead of print].","DOI":"10.1016\/j.jhep.2012.10.019"},{"key":"ref8","first-page":"311","article-title":"Orf","volume":"29","author":"DM Haig","year":"1989","journal-title":"Vet Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/JVI.71.6.4857-4861.1997","article-title":"A homolog of interleukin-10 is encoded by the poxvirus orf virus","volume":"71","author":"SB Fleming","year":"1997","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2567.1998.00438.x","article-title":"The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase","volume":"93","author":"DM Haig","year":"1998","journal-title":"Immunology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1099\/vir.0.19138-0","article-title":"Inactivated <italic>Parapoxvirus ovis<\/italic> (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus","volume":"84","author":"O Weber","year":"2003","journal-title":"J Gen Virol"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Nowatzky J, Knorr A, Hirth-Dietrich C, Siegling A, Volk H-D, <etal>et al<\/etal>.. (2012) Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis. Hepatol Res Sep 13. doi:10.1111\/j.1872-034X.2012.01086.x. [Epub ahead of print].","DOI":"10.1111\/j.1872-034X.2012.01086.x"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-2427(94)05357-X","article-title":"Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs","volume":"46","author":"M B\u00fcttner","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"V Lohmann","year":"1999","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/JVI.75.10.4614-4624.2001","article-title":"Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations","volume":"75","author":"N Krieger, N Krieger","year":"2001","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1128\/AAC.49.4.1346-1353.2005","article-title":"Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay","volume":"49","author":"DR O\u2019Boyle 2nd","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.vaccine.2008.01.032","article-title":"Development and optimization of a procedure for the production of parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium","volume":"26","author":"M Pohlscheidt","year":"2008","journal-title":"Vaccine"},{"key":"ref18","first-page":"156","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-Phenolchloroform extraction. Anal","volume":"162","author":"P Chromczynski","year":"1987","journal-title":"Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0166-3542(01)00216-9","article-title":"Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model","volume":"54","author":"O Weber","year":"2002","journal-title":"Antiviral Res"},{"key":"ref20","first-page":"12","article-title":"Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol","volume":"36","author":"G Wingender","year":"2006"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.1840160623","article-title":"Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis","volume":"16","author":"E Bhunchet","year":"1992","journal-title":"Hepatology"},{"key":"ref22","first-page":"1348","article-title":"Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med","volume":"(12)","author":"A Limmer","year":"2000","journal-title":"6"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.4049\/jimmunol.150.7.2724","article-title":"Endogenous generation and presentation of the ovalbumin peptide\/Kb complex to T cells","volume":"150","author":"N Shastri","year":"1993","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"R Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"V Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Weber O, Mercer AA, Friebe A, Knolle P, Volk H-D (2012) Therapeutic immunomodulation using a virus\u2013the potential of inactivated orf virus. Eur J Clin Microbiol Infect Dis DOI 10.1007\/s10096-012-1780-x, published online on Nov 22, ahead of print.","DOI":"10.1007\/s10096-012-1780-x"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1128\/JVI.78.17.9400-9411.2004","article-title":"Immunomodulatory effects of inactivated Parapoxvirus ovis (ORF virus) on human peripheral immune cells: inductionof cytokine secretion in monocytes and Th1-like cells","volume":"78","author":"A Friebe","year":"2004","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nature Rev Immunol 12, 557\u2013569.","DOI":"10.1038\/nri3254"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Burgdorf S, Sch\u00f6lz C, Kautz A, Tamp\u00e9 R, Kurts C (2008) Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation Nat. Immunol 9, 558\u2013566.","DOI":"10.1038\/ni.1601"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.gastro.2009.08.057","article-title":"Virally Infected Mouse Liver Endothelial Cells Trigger CD8+ T-Cell Immunity","volume":"138","author":"M Kern","year":"2010","journal-title":"Gastroenterol"},{"key":"ref31","first-page":"187","article-title":"Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med","volume":"(2)","author":"M Heikenwalder","year":"2004","journal-title":"10"},{"key":"ref32","first-page":"86","article-title":"Toll-like receptor 9 processing: the key event in toll-like recptor 9 activation? Immunol Lett","volume":"(1\u20132)","author":"S Bauer","year":"2013","journal-title":"149"},{"key":"ref33","first-page":"9411","article-title":"Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha\/beta interferon in response to inactivated parapoxvirus ovis. J Virol","volume":"83","author":"S Siegemund","year":"2009"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/JVI.75.10.4699-4704.2001","article-title":"Selective induction of apoptosis in antigen-presenting cells in mice by parapoxvirus ovis","volume":"75","author":"N Kruse","year":"2001","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/intimm\/11.5.657","article-title":"IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo","volume":"(5)","author":"T Matsuhita","year":"1999","journal-title":"Intern Immunology 11"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.4049\/jimmunol.168.8.3763","article-title":"Activating immunity in the liver. II. IFN b attenuates NK cell-dependent liver injury triggered by liver NKT cell activation","volume":"168","author":"Z Trobonjaca","year":"2012","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.celrep.2012.08.001","article-title":"TNF-induced target cell killing by CTL activated through cross-presentation","volume":"2","author":"D Wohlleber","year":"2012","journal-title":"Cell Rep"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virusres.2005.09.011","article-title":"Comparative analysis of genome sequences of three isolates of Orf virus reveals unexpected sequence variation","volume":"116","author":"AA Mercer","year":"2006","journal-title":"Virus Research"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01315174","article-title":"The genome of orf virus: restriction endonuclease analysis of viral DNA isolated from lesions of orf in sheep","volume":"71","author":"AJ Robinson","year":"1982","journal-title":"Arch Virol"},{"key":"ref40","first-page":"4","article-title":"Novel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome. Proteome Sci","volume":"10(1)","author":"MJ McGuire","year":"2012","journal-title":"Jan 13"},{"key":"ref41","first-page":"53","article-title":"Analysis of genomic rearrangement and subsequent gene deletion of the attenuated Orf virus strain D1701 Virus Res","volume":"56","author":"R Cottone","year":"1998"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JVI.80.2.553-561.2006","article-title":"Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression","volume":"80","author":"S Parrish","year":"2006","journal-title":"J Virol"},{"key":"ref43","first-page":"3353","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo J Virol","volume":"74","author":"C-L Lin","year":"2000"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1099\/vir.0.028894-0","article-title":"Characterization of immunostimulatory components of Orf virus (parapoxvirus ovis)","volume":"92","author":"A Friebe","year":"2011","journal-title":"J Gen Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.510230538","article-title":"Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis","volume":"23","author":"GS Baroni","year":"1996","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.1840160325","article-title":"Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma","volume":"16","author":"DC Rockey","year":"1992","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jhep.2006.09.014","article-title":"IFN-\u03b3 abrogates profibrotic TGF-\u00df signaling in liver by targeting expression of inhibitory and receptor Smads","volume":"46","author":"H Weng","year":"2007","journal-title":"J Hepatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/01902149509050842","article-title":"Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression","volume":"21","author":"G Gurujeyalakshmi","year":"1995","journal-title":"Experimental Lung Research"},{"key":"ref49","first-page":"4788","article-title":"Effect of IL-10 on the expression of HSC growth factors in hepatic fibrosis rats World J Gastroenterol","volume":"31","author":"MN Shi","year":"2005"},{"key":"ref50","first-page":"2357","article-title":"Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10","volume":"15","author":"MN Shi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1074\/jbc.273.1.302","article-title":"Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells","volume":"273","author":"SC Wang","year":"1998","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T16:08:46Z","timestamp":1688486926000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074605"}},"subtitle":[],"editor":[{"given":"Rafael","family":"Aldabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,16]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074605","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,16]]}}}